Zoltan Sarnyai

2003-2011 Pharmacology University of Cambridge, Cambridge, England, United Kingdom 
 2012- Laboratory of Psychiatric Neuroscience James Cook University 
stress and mental health, psychopharmacology
"Zoltan Sarnyai"

Dr Zoltán Sarnyai is a medically-trained PhD neuroscientist with an active research program in the neurobiological mechanisms of stress and psychiatric disorders, including drug addiction, schizophrenia and depression. After a postdoctoral training at Harvard Medical School he held an independent research position at the Rockefeller University, supported by two prestigious fellowships. Zoltán was involved in setting up a behavioural neuroscience focussed biotech company and later directed its research effort to develop new animal models for psychiatric disorders. Prior to establishing the Psychiatric Neuroscience Laboratory at JCU in 2012 he was a University Lecturer in Pharmacology and Fellow of Pembroke College at the University of Cambridge.

(Show more)

Mean distance: 13.63 (cluster 7)
Cross-listing: Chemistry Tree


Sign in to add trainee
Maximus Berger grad student 2015- JCU
Yolanda Kerlen grad student 2015- JCU
Ann Katrin Kraeuter grad student 2015- JCU
Vanessa Wong grad student 2015- JCU
Maki Kasahara grad student 2004-2008 Cambridge


Sign in to add collaborator
Berend Olivier collaborator 2003- Utrecht
Sabine Bahn collaborator 2009- Cambridge
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Amminger GP, Lin A, Kerr M, et al. (2021) Cannabidiol for at risk for psychosis youth: A randomized controlled trial. Early Intervention in Psychiatry
Phillips R, Kraeuter AK, McDermott B, et al. (2020) Human nail cortisol as a retrospective biomarker of chronic stress: A systematic review. Psychoneuroendocrinology. 123: 104903
Kraeuter AK, Phillips R, Sarnyai Z. (2020) The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies. Frontiers in Psychiatry. 11: 799
Sarnyai Z, Palmer CM. (2020) Ketogenic Therapy in Serious Mental Illness: Emerging Evidence. The International Journal of Neuropsychopharmacology
Berger M, Amminger GP, McDermott R, et al. (2020) Testing the Effects of Dietary Seafood Consumption on Depressive Symptoms. Methods in Molecular Biology (Clifton, N.J.). 2138: 233-242
Kraeuter AK, Guest PC, Sarnyai Z. (2020) Protocol for the Use of the Ketogenic Diet in Preclinical and Clinical Practice. Methods in Molecular Biology (Clifton, N.J.). 2138: 83-98
Kraeuter AK, Phillips R, Sarnyai Z. (2020) Ketogenic therapy in neurodegenerative and psychiatric disorders: From mice to men. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109913
Ketheesan S, Rinaudo M, Berger M, et al. (2020) Stress, Allostatic Load and Mental Health in Indigenous Australians. Stress (Amsterdam, Netherlands). 1-26
Kraeuter AK, Mashavave T, Suvarna A, et al. (2020) Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice. Psychopharmacology
Suvarna B, Suvarna A, Phillips R, et al. (2019) Health risk behaviours and allostatic load: A systematic review. Neuroscience and Biobehavioral Reviews
See more...